Halozyme Therapeutics | HALO - Market Capitalization

Stock Price
63.27
Daily Change
-0.38 -0.60%
Monthly
-10.86%
Yearly
-1.63%
Q1 Forecast
61.74

Halozyme Therapeutics reported $8.09B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 308M 18M Mar/2026
Amgen USD 176.25B 24.32B Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Cara Therapeutics USD 28M 11M Dec/2024
Cytokinetics USD 7.77B 1.19B Dec/2025
DBV Technologies USD 745M 471M Mar/2026
Eli Lilly USD 1.02T 293.84B Dec/2025
Esperion Therapeutics USD 475M 410M Mar/2026
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
MannKind USD 1.74B 93M Dec/2025
Pfizer USD 153.96B 12.4B Mar/2026
United Therapeutics USD 20.98B 2.02B Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024